The Role Of BRAF Mutations In Treatment Of Cholangiocarcinoma

The Role Of BRAF Mutations In Treatment Of Cholangiocarcinoma

obr

1 year
76 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Richard Kim, MD, Gastrointestinal Oncology Department, Moffitt Cancer Center, Assistant Professor of Oncology, University of South Florida College of Medicine, discusses The Role Of BRAF Mutations In Treatment Of Cholangiocarcinoma. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com
Up Next Autoplay